NEWHALL CHARLES W III received a stock award from SUPERNUS PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/27/2024ACC: 0001104659-24-028281
Director
Since Feb 2026
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
3.89K acquired · 3.89K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+3.89K
Price / share
—
Trade value
—
% of position
3.3%
2/23/2024
117.09K→120.97K
Total
Net shares
+3.89K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/23/2024 | A · Award | +3.89K | — | — | 3.3% | 117.09K | 120.97K |
| Total | +3.89K | $0.00 | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
3.89K shares
Shares
−3.89K
Strike price
Held after
0.00
Exercisable
—
2/23/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock3.89K shares | 2/23/2024 | D · Disposition | −3.89K | — | 0.00 |